Venture-Backed Startups

Biotoken connects regenerative agricultural producers with organizations seeking to offset carbon emissions through a decentralized marketplace. The platform tokenizes carbon capture from farms into tradeable digital assets (TCOE), enabling transparent verification and direct transactions between carbon generators and compensators.

1 investor

0 investors

The page presents cardiac interventional and electrophysiology products—including transseptal sheaths and needles, occlusion balloons, guiding sheaths, guidewires, hemostasis valves, and compression devices—branded under Merit Medical for use in procedures such as lead extraction, cardiac resynchronization therapy, and CRM implantations. The products are aimed at electrophysiologists and cardiac care clinicians.

1 investor

1 investor

Biotree (上海百趣) is a Shanghai-based provider of mass spectrometry–based multi-omics products and services, specializing in metabolomics and proteomics. It offers research services (targeted/untargeted metabolomics, proteomics, single-cell and spatial omics, sequencing), biopharma analytical services, and clinical/medical translation services including diagnostic test kits and CDMO work, serving universities, research institutes, hospitals, and companies primarily in China.

1 investor

Biotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.

0 investors

Biotronics3D provides a cloud-based, zero-footprint medical imaging platform with RIS and PACS functionality, teleradiology modules, and AI-assisted diagnostic tools for hospitals, clinics, imaging centers, and teleradiology providers. The platform supports image routing, reporting, and workflow management, and is used across more than 400 sites in Europe.

1 investor

Biotts develops transdermal drug delivery products using its proprietary MTC-Y carrier system, a semisolid emulsion that transports both lipophilic and hydrophilic molecules up to 6,000 Da (including peptides and proteins) through the skin. The company creates its own transdermal drug products and licenses its technology and development expertise to the pharmaceutical industry.

2 investors

BioTuring is a bioinformatics company that builds algorithms and software for analyzing biological data, including single-cell and genomic data. It serves the global scientific research community working to understand biology and improve human health.

0 investors

BioVana operates a secure, federated network (the BioVana Index) that makes African biobank data discoverable to global researchers without moving samples, and offers ISO 20387-compliant sample-tracking software (Sampletrack). It provides access to African biospecimens and research-ready datasets for precision cohort discovery in the biotech and health research market.

1 investor

BIOVECTRA is a full-service contract development and manufacturing organization (CDMO) producing biologics, small molecules, bioreagents, and HPAPIs, with expertise in microbial fermentation and complex chemistry. It supports pharmaceutical and biotech clients from clinical to commercial-stage product development and manufacturing, operating in Canada across Prince Edward Island and Nova Scotia.

2 investors

BioVendor is a company active in laboratory diagnostics that also supports education initiatives connecting young talent with practical scientific experience.

1 investor

1 investor

Bioventus develops orthobiologics and pain treatment products for orthopedic care, offering therapies such as the StimRouter neurostimulation device for chronic peripheral nerve pain. Its portfolio serves patients, physicians, and payers in the medical device and healing space.

3 investors

1 investor

BioVeritas has developed a proprietary process that converts biomass—including wastes, residues, and purpose-grown crops—into a drop-in feedstock for existing refining and production capacity. The company initially targets sustainable aviation fuel (SAF) and renewable diesel (RD) via integration with HEFA production, with plans to extend the platform to other low-carbon fuels, chemicals, and products.

1 investor

Bioverse maps forest cover and species prevalence using satellite, drone, and AI/machine learning technologies to improve non-timber forest product harvesting, verify carbon and biodiversity credits, and support forest regeneration. It serves nature-based solution project developers and the cosmetics, food, and pharmaceutical industries across the Amazon Basin and other tropical biomes.

1 investor

BioVersys is a Swiss pharmaceutical company developing small-molecule drugs with novel modes of action to treat drug-resistant bacterial infections, addressing antimicrobial resistance (AMR). Its pipeline targets serious hospital infections such as A. baumannii, S. aureus, and NTM infections.

2 investors

0 investors

Biovision Diagnostics operates a clinical diagnostic laboratory providing medical testing services to healthcare providers and organizations, focusing on faster turnaround times, proprietary testing methods, and competitive pricing. It serves clients and their patients through lab services intended to improve diagnostic quality.

0 investors

0 investors

Biovox works with PLA (polylactic acid), a biobased polymer, and evaluates its use as a material for drug delivery devices such as autoinjectors. The company focuses on sustainable material solutions for medical/pharmaceutical device applications.

1 investor

BIOW develops solutions targeting the health effects of air pollution exposure, specifically investigating how bioavailable anions may support mitochondrial function and neural resilience in the context of neurodegenerative diseases and aging. The company conducts clinical research on biomarker changes and microbiome effects through advanced proteomics and metabolomics analysis.

1 investor

BioWare is a video game studio that develops single-player role-playing games known for story-driven worlds and characters, including the Dragon Age and Mass Effect franchises. Its games are published for players through EA.

1 investor